Evolent Health Inc’s recent filing unveils that its PRESIDENT McCarthy Daniel Joseph unloaded Company’s shares for reported $0.73 million on Aug 22 ’24. In the deal valued at $30.89 per share,23,693 shares were sold. As a result of this transaction, McCarthy Daniel Joseph now holds 198,809 shares worth roughly $2.36 million.
Then, McCarthy Daniel Joseph sold 10,469 shares, generating $339,008 in total proceeds. Upon selling the shares at $32.38, the PRESIDENT now owns 188,340 shares.
Before that, Weinberg Jonathan sold 42,140 shares. Evolent Health Inc shares valued at $1,314,706 were divested by the General Counsel at a price of $31.20 per share. As a result of the transaction, Weinberg Jonathan now holds 167,027 shares, worth roughly $1.98 million.
BTIG Research reiterated its Evolent Health Inc [EVH] rating to a Buy in a research note published on December 03, 2024; the price target was $29. A number of analysts have revised their coverage, including Stephens’s analysts, who decreased its forecast for the stock in early November from “an Overweight” to “an Equal-weight”. KeyBanc Capital Markets began covering EVH with “an Overweight” recommendation on October 11, 2024. Truist revised its rating on August 09, 2024. It rated EVH as “a Buy” which previously was an “a Hold”.
Price Performance Review of EVH
On Friday, Evolent Health Inc [NYSE:EVH] saw its stock jump 3.39% to $11.88. Over the last five days, the stock has gained 4.76%. Evolent Health Inc shares have risen nearly 5.60% since the year began. Nevertheless, the stocks have fallen -62.46% over the past one year. While a 52-week high of $35.00 was reached on 01/03/25, a 52-week low of $10.53 was recorded on 01/03/25. SMA at 50 days reached $14.71, while 200 days put it at $23.17.
Levels Of Support And Resistance For EVH Stock
The 24-hour chart illustrates a support level at 11.46, which if violated will result in even more drops to 11.03. On the upside, there is a resistance level at 12.10. A further resistance level may holdings at 12.31. The Relative Strength Index (RSI) on the 14-day chart is 45.39, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.30, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 0.74%. Stochastics %K at 73.06% indicates the stock is a holding.
How much short interest is there in Evolent Health Inc?
A steep rise in short interest was recorded in Evolent Health Inc stocks on 2024-12-13, dropping by -1.06 million shares to a total of 9.76 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 10.82 million shares. There was a decline of -10.88%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on April 22, 2024 when Citigroup began covering the stock and recommended ‘”a Buy”‘ rating along with a $40 price target.
